![White car (Porsche Taycan) with the hood popped is inside the building with an american flag on the wall.](/sites/default/files/styles/featured_square_large/public/2024-06/2024-P09317.jpg?h=8f9cfe54&itok=m6sQhZRq)
Filter News
Area of Research
- (-) Biology and Environment (19)
- (-) Neutron Science (7)
- Clean Energy (28)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (2)
- Isotopes (2)
- Materials (13)
- Materials for Computing (1)
- National Security (16)
- Nuclear Science and Technology (2)
- Quantum information Science (2)
- Supercomputing (44)
News Topics
- (-) Artificial Intelligence (8)
- (-) Coronavirus (7)
- (-) Mathematics (3)
- (-) Microscopy (8)
- (-) Space Exploration (1)
- (-) Summit (8)
- 3-D Printing/Advanced Manufacturing (5)
- Big Data (7)
- Bioenergy (28)
- Biology (43)
- Biomedical (13)
- Biotechnology (6)
- Chemical Sciences (4)
- Clean Water (10)
- Climate Change (23)
- Composites (1)
- Computer Science (17)
- Decarbonization (16)
- Energy Storage (4)
- Environment (60)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (3)
- High-Performance Computing (13)
- Hydropower (5)
- Machine Learning (7)
- Materials (6)
- Materials Science (9)
- Mercury (6)
- Nanotechnology (4)
- National Security (3)
- Net Zero (1)
- Neutron Science (33)
- Nuclear Energy (1)
- Physics (2)
- Polymers (2)
- Quantum Computing (1)
- Quantum Science (1)
- Renewable Energy (1)
- Security (2)
- Simulation (9)
- Sustainable Energy (17)
- Transportation (1)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![ORNL researchers are leading virtual STEM outreach activities, such as an Internet of Things demonstration in which participants in ORCSGirls control an LED board remotely.](/sites/default/files/styles/list_page_thumbnail/public/2020-06/200411_ogi_0055_0.jpg?h=28121b77&itok=ucPjaIJO)
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
![Omar Demerdash](/sites/default/files/styles/list_page_thumbnail/public/2020-05/demerdash_crop.jpg?h=8831409f&itok=2J2gUqDr)
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
![Coronavirus graphic](/sites/default/files/styles/list_page_thumbnail/public/2020-04/covid19_jh_0.png?h=d1cb525d&itok=PyngFUZw)
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.